Navigation Links
Europe gets together to harness quantum physics
Date:6/5/2008

The long cherished goal of applying the strange properties of quantum mechanics to the macroscopic world we inhabit has been brought closer by a series of recent developments. The exciting progress was made in the important field of quantum optics and discussed recently at a high level conference organised by the European Science Foundation in collaboration with the Fonds zur Frderung der wissenschaftlichen Forschung in sterreich (FWF) and the Leopold-Franzens-Universitt Innsbruck (LFUI).

Quantum optics is fundamental to the whole field of quantum science, because it deals with the interactions between light and matter at the elementary level that determine ultimately how atoms and molecules behave. A thorough understanding of quantum optics in its broadest sense has the potential to lead to new (quantum) technologies that will help define the 21st century, according to Professor Jrg Schmiedmayer, who chaired the ESF conference.

Quantum science has great potential to revolutionise the worlds of computing and communications, enabling massive increases in processing power, data storage densities, and data transfer rates. Although most of the applications are still many years away, dramatic progress has been made laying the groundwork for projects at the laboratory level that demonstrate the concepts on a small scale. A gratifying aspect of the conference, according to Schmiedmayer, was the exceptionally high standard of contributions made, and excitement generated, by young researchers, who will be the standard bearers for the field over the important two decades to come. "The hot topic sessions, where mostly young researches presented their results, were definitively among the highlights of the conference," said Schmiedmayer. "At these very new science was discussed, science that was not even envisioned three years ago. Many results had not yet been presented elsewhere before."

Significant progress was noted for example in quantum communication,
'/>"/>

Contact: Hans Chrisoph Ngerl
Christoph.Naegerl@uibk.ac.at
43-512-507-6316
European Science Foundation
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Securing the future of Europes biological data resources
2. European light research opens door for optical storage and computing
3. Europe develops new technologies to boost health of livestock
4. European membrane expertise to focus on new treatments for human diseases
5. ESFs European ice core project EPICA receives prestigious Descartes Prize
6. Europes most common genetic disease is a liver disorder
7. First European Lung Cancer Conference
8. Final preparations for first human-rated spacecraft to be lauched from Europes Spaceport
9. EMBO Installation Grants help 9 scientists set up in Europe
10. European Union forests expanding, absorbing carbon at surprisingly high rate: study
11. IdentiPHI Opens Paris Office to Boost European Sales and Support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... 23, 2015   MedNet Solutions , an ... entire spectrum of clinical research, is pleased to ... , the company,s intuitive, flexible and affordable cloud-based ... 2015 Stevie® Award by the American Business ... Website category.  The American Business Awards are considered ...
(Date:6/18/2015)... 2015 This report analyzes the worldwide markets ... Product Segments, which includes Immunoassay Analyzers and Reagents: Enzyme ... Immunoassay Systems, and Nephelometric Immunoassay Systems. The report provides ... , Japan , ... Latin America , and Rest of World. ...
(Date:6/17/2015)... Calif. , June 17, 2015  Synaptics ... human interface solutions, today announced that Xiaomi, one ... the Synaptics ® ClearPad ® family ... display driver integrated circuits (DDICs) for its latest ... By leveraging ClearPad for full in-cell display solutions ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... short-lived animals (insects, worms, mice) under benign conditions ... food in the laboratory. Oddly enough, very ... in their harsh, stressful natural environments. Could it ... much more slowly in captive luxury than do ...
... Bats, ability to echolocate may have evolved more than once, ... of London scientists. Species of bat with the ability ... tree of life - some are more related to their ... of whether echolocation in bats has evolved more than once, ...
... 5 September 2008 Even scientists define ,a gene, in different ... have various ways of framing the concept of a gene, according ... EMBO reports . , The study, Frame that gene, is ... newspapers: The Guardian, The Sun and The Daily Mail from the ...
Cached Biology News:Old before their time? Aging in flies under natural vs. laboratory conditions 2Molecular evolution is echoed in bat ears 2What is a gene? 2
(Date:6/30/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company focused on the development of autologous cell ... Phase 1/2 clinical trial of RCT-01, being tested ... has been enrolled and their tissue biopsy sent ... is comprised of non-bulbar dermal sheath (NBDS) cells ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... 14. She has accepted the position of vice president of instruction at Chippewa ... , “I greatly appreciated the opportunity to lead SIUE during the past ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... digital media company, launched “Cannavoices,” an unprecedented digital video and broadcast initiative. ... but also the most dynamic collection of legal medical cannabis stories ever assembled. ...
(Date:6/29/2015)... June 30, 2015   Pharnext SAS today announced ... for the treatment of Charcot-Marie-Tooth Type 1A (CMT1A), is being ... 2015 Peripheral Nerve Society (PNS) Biennial Meeting at the Quebec ... June 27 - July 2, 2015. At Poster ... July 1, 5p.m. to 7p.m. EDT: Poster ...
Breaking Biology Technology:RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2
... Md., Oct. 1 Novavax, Inc. (Nasdaq: NVAX ... the board,s corporate governance, compensation and finance committees, replacing board ... James Tananbaum who is retiring from the board. Mr. ... immunology products companies and joined the Novavax board in June ...
... Oct. 1 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG) ... and affordable vaccines based on proprietary manufacturing technologies ... has initiated a Phase I human clinical trial ... Enrolment is ongoing and vaccination has commenced. The ...
... ... Administration (USFDA) will host Assessing Benefits and Risks of Medicinal Products in Regulatory Decisions from ... ... (DIA) and the US Food and Drug Administration (USFDA) will host Assessing Benefits ...
Cached Biology Technology:Novavax Announces Board of Director Changes 2Novavax Announces Board of Director Changes 3Medicago begins human clinical testing with its avian flu pandemic vaccine 2Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop 2Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop 3
...
... The Antibody Validation Service enables ... for further development by providing quantitative ... detection limit of each antibody. Furthermore ... revealing the off-target activity of your ...
... results sooner and save hours of valuable research ... need for a membrane transfer step and western ... No reagents to prepare or mix or dilute ... a simple to perform, mistake-free detection protocol. ...
... paper sandwiches are composed of a precut ... thick filter paper that are preassembled into ... These 7 x 8.5 cm membrane sandwiches ... Gel-sized gels and are supplied as a ...
Biology Products: